Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 NICE's cost effectiveness threshold.

Literature DB >> 17717337

NICE's cost effectiveness threshold.

John Appleby, Nancy Devlin, David Parkin.

Abstract

Mesh：

Year: 2007 PMID： 17717337 PMCID： PMC1952475 DOI： 10.1136/bmj.39308.560069.BE

Source DB: PubMed Journal: BMJ ISSN： 0959-8138

× No keyword cloud information.

3 in total

1. Does NICE have a cost-effectiveness threshold and what other factors influence its decisions? A binary choice analysis.

Authors: Nancy Devlin; David Parkin
Journal: Health Econ Date: 2004-05 Impact factor: 3.046

2. National Institute for Clinical Excellence and its value judgments.

Authors: Michael D Rawlins; Anthony J Culyer
Journal: BMJ Date: 2004-07-24

3. "Yes", "No" or "Yes, but"? Multinomial modelling of NICE decision-making.

Authors: Helen Angela Dakin; Nancy J Devlin; Isaac A O Odeyemi
Journal: Health Policy Date: 2005-10-05 Impact factor: 2.980

3 in total

60 in total

1. Should the NHS be privatized? Annual varsity medical debate - London, 22 January 2010.

Authors: Myura Nagendran; Sanjay Budhdeo; Mahiben Maruthappu; Kapil Sugand
Journal: Philos Ethics Humanit Med Date: 2010-05-11 Impact factor: 2.464

2. The impact of using different tariffs to value EQ-5D health state descriptions: an example from a study of acute cough/lower respiratory tract infections in seven countries.

Authors: Raymond Oppong; Billingsley Kaambwa; Jacqueline Nuttall; Kerenza Hood; Richard D Smith; Joanna Coast
Journal: Eur J Health Econ Date: 2011-11-05

3. Cost Effectiveness of IDegLira vs. Alternative Basal Insulin Intensification Therapies in Patients with Type 2 Diabetes Mellitus Uncontrolled on Basal Insulin in a UK Setting.

Authors: Melanie J Davies; Divina Glah; Barrie Chubb; Gerasimos Konidaris; Phil McEwan
Journal: Pharmacoeconomics Date: 2016-09 Impact factor: 4.981

NICE's cost effectiveness threshold.

1. Does NICE have a cost-effectiveness threshold and what other factors influence its decisions? A binary choice analysis.

2. National Institute for Clinical Excellence and its value judgments.

3. "Yes", "No" or "Yes, but"? Multinomial modelling of NICE decision-making.

1. Should the NHS be privatized? Annual varsity medical debate - London, 22 January 2010.

2. The impact of using different tariffs to value EQ-5D health state descriptions: an example from a study of acute cough/lower respiratory tract infections in seven countries.

3. Cost Effectiveness of IDegLira vs. Alternative Basal Insulin Intensification Therapies in Patients with Type 2 Diabetes Mellitus Uncontrolled on Basal Insulin in a UK Setting.

4. NICE behaviour: QALYs in the community.

5. Healthcare rationing by proxy: cost-effectiveness analysis and the misuse of the $50,000 threshold in the US.

6. From rationing to rational: the evolving status of NICE.

7. Isolated otitis media with effusion in adults: is biopsy of the postnasal space required?

8. Determining the economic cost of ICU treatment: a prospective "micro-costing" study.

9. Cost-Effectiveness Analysis of Tyrosine Kinase Inhibitors for Patients with Advanced Gastrointestinal Stromal Tumors.

Review 10. [Cochlear implant treatment in Germany].